Paradigm Biopharmaceuticals (ASX:PAR) Machinery, Furniture, Equipment : A$0.26 Mil (As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Paradigm Biopharmaceuticals Machinery, Furniture, Equipment?

Paradigm Biopharmaceuticals's Machinery, Furniture, Equipment for the quarter that ended in Dec. 2023 was A$0.26 Mil.

Paradigm Biopharmaceuticals's quarterly Machinery, Furniture, Equipment declined from Dec. 2022 (A$0.41 Mil) to Jun. 2023 (A$0.19 Mil) but then increased from Jun. 2023 (A$0.19 Mil) to Dec. 2023 (A$0.26 Mil).

Paradigm Biopharmaceuticals's annual Machinery, Furniture, Equipment stayed the same from Jun. 2021 (A$0.19 Mil) to Jun. 2022 (A$0.19 Mil) and stayed the same from Jun. 2022 (A$0.19 Mil) to Jun. 2023 (A$0.19 Mil).

Paradigm Biopharmaceuticals Machinery, Furniture, Equipment Historical Data

The historical data trend for Paradigm Biopharmaceuticals's Machinery, Furniture, Equipment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Paradigm Biopharmaceuticals Machinery, Furniture, Equipment Chart

Paradigm Biopharmaceuticals Annual Data

Trend

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Machinery, Furniture, Equipment

Get a 7-Day Free Trial

0.05

0.16

0.19

Paradigm Biopharmaceuticals Semi-Annual Data
	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Machinery, Furniture, Equipment	Get a 7-Day Free Trial												0.67	0.19	0.41	0.19	0.26

Paradigm Biopharmaceuticals Machinery, Furniture, Equipment Calculation

Machinery, Furniture, Equipment represents those fixed assets specifically dealing with tools, equipment and office furniture.

Paradigm Biopharmaceuticals (ASX:PAR) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Paradigm Biopharmaceuticals Ltd (ASX:PAR) » Definitions » Machinery, Furniture, Equipment

Comparable Companies

Traded in Other Exchanges

PBIGF:USA

Address

500 Collins Street, Level 15, Melbourne, VIC, AUS, 3000

Website

https://www.paradigmbiopharma.com

Paradigm Biopharmaceuticals Ltd is a biopharmaceutical company that engages in the research and development of therapeutic products for human use in Australia. The firm is engaged in drug repurposing, pentosan polysulphate sodium (PPS) for the lead clinical indication of bone marrow edema, Alphavirus - Ross River virus (RRV) and Chikungunya virus (CHIKV), Mucopolysaccharidosis, and allergic respiratory conditions, including allergic rhinitis (AR) and chronic obstructive pulmonary disease (COPD).